Search

Displaying results 4351 - 4360 of 10000 in total
  1. Drug

    Tertomotide

    go.drugbank.com/drugs/DB12747
    Investigational

    Tertomotide is under investigation in clinical trial NCT01223209 (A Study, Combination, Immunologic Study of LTX-315 as adjunct to tertomotide in Patients Following Curative Surgery for Carcinoma). … It is a peptide vaccine that activates the immune system so that it recognizes and kills cancer cells. It is being developed by Pharmexa A/S.

  2. Drug

    Iroxanadine

    go.drugbank.com/drugs/DB05444
    Experimental

    It induces phosphorylation of p38 SAPK, which plays an important role in EC homeostasis. endothelial cell (EC). … EC function plays a central role in vascular diseases (e.g. atherosclerosis, restenosis, diabetic angiopathies, microvascular angina, peripheral arterial disease).

  3. Drug

    Cymarin

    go.drugbank.com/drugs/DB13240
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  4. Drug

    Fosfructose

    go.drugbank.com/drugs/DB13863
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  5. Drug

    Glyphosate

    go.drugbank.com/drugs/DB04539
    Experimental

    Categories: Compounds used in a research, industrial, or household setting, N-substituted Glycines
  6. Drug

    Rhodamine 6G

    go.drugbank.com/drugs/DB03825
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  7. Drug

    Bromodiphenhydramine

    go.drugbank.com/drugs/DB01237
    Approved

    Bromodiphenhydramine is an ethanolamine antihistamine with antimicrobial property. Bromodiphenhydramine is used in the control of cutaneous allergies. … Ethanolamine antihistamines produce marked sedation in most patients.

    Synonyms: 2-(p-bromo-α-phenylbenzyloxy)-N,N-dimethylethylamine
  8. Drug

    Siplizumab

    go.drugbank.com/drugs/DB06371
    Investigational

  9. Drug

    PW2101

    go.drugbank.com/drugs/DB06483
    Experimental

    The drug was developed by Penwest Pharmaceuticals and in 2005 the FDA issues a Non-Approval letter due to the degree of kinetic variability of PW2101 observed among individuals. … PW2101 is a beta blocker intended for the treatment of hypertension and angina.

  10. Drug

    GTI 2040

    go.drugbank.com/drugs/DB05801
    Investigational

    GTI-2040 is a substance that is being studied as a treatment for cancer. It belongs to the family of drugs called antisense oligonucleotides.